These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18458846)

  • 21. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.
    Kimura Y; Hyogo H; Yamagishi S; Takeuchi M; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
    J Gastroenterol; 2010 Jul; 45(7):750-7. PubMed ID: 20112031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end product (AGE)-induced hepatic stellate cell activation via autophagy contributes to hepatitis C-related fibrosis.
    He Y; Zhu J; Huang Y; Gao H; Zhao Y
    Acta Diabetol; 2015 Oct; 52(5):959-69. PubMed ID: 26002589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation.
    Inagaki Y; Yamagishi S; Okamoto T; Takeuchi M; Amano S
    Diabetologia; 2003 Feb; 46(2):284-7. PubMed ID: 12627328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro.
    Dong N; Li X; Xiao L; Yu W; Wang B; Chu L
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7567-75. PubMed ID: 23010641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death.
    Dunning S; Ur Rehman A; Tiebosch MH; Hannivoort RA; Haijer FW; Woudenberg J; van den Heuvel FA; Buist-Homan M; Faber KN; Moshage H
    Biochim Biophys Acta; 2013 Dec; 1832(12):2027-34. PubMed ID: 23871839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
    Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
    Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end products affect growth and function of osteoblasts.
    Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
    Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
    Berrou J; Tostivint I; Verrecchia F; Berthier C; Boulanger E; Mauviel A; Marti HP; Wautier MP; Wautier JL; Rondeau E; Hertig A
    Int J Mol Med; 2009 Apr; 23(4):513-20. PubMed ID: 19288028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells.
    Itagaki T; Shimizu I; Cheng X; Yuan Y; Oshio A; Tamaki K; Fukuno H; Honda H; Okamura Y; Ito S
    Gut; 2005 Dec; 54(12):1782-9. PubMed ID: 16284289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products.
    Baek GH; Jang YS; Jeong SI; Cha J; Joo M; Shin SW; Ha KT; Jeong HS
    Inflammation; 2012 Aug; 35(4):1232-41. PubMed ID: 22327862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advanced glycation end products stimulate human endothelial cells to produce monocyte chemoattractant protein-1].
    Guo ZJ; Hou FF; Liang M; Wang L; Zhang X; Liu ZQ
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1075-9. PubMed ID: 12899782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
    Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
    J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes.
    Unoki H; Bujo H; Yamagishi S; Takeuchi M; Imaizumi T; Saito Y
    Diabetes Res Clin Pract; 2007 May; 76(2):236-44. PubMed ID: 17097186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis.
    Priken K; Tapia G; Cadagan C; Quezada N; Torres J; D'Espessailles A; Pettinelli P
    Nutr Res; 2022 Aug; 104():71-81. PubMed ID: 35635899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylglyoxal and advanced glycation end-products promote cytokines expression in peritoneal mesothelial cells via MAPK signaling.
    Hong FY; Bao JF; Hao J; Yu Q; Liu J
    Am J Med Sci; 2015 Feb; 349(2):105-9. PubMed ID: 25581570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation.
    Amer J; Salhab A; Doron S; Morali G; Safadi R
    Cytometry A; 2018 Apr; 93(4):427-435. PubMed ID: 29517852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.